Tamiflu (oseltamivir phosphate) Capsules and Oral Suspension

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)  June 2016 WARNINGS AND PRECAUTIONS Serious Skin/Hypersensitivity Reactions (Addition of sentence to section)The use of...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts